JP3634200004 (JP3634200004)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 8/9, Altman Z 3.3 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation profile presents a nuanced picture of operational efficiency versus growth momentum. While the DuPont decomposition reveals that profitability is driven primarily by margins rather than asset turnover or leverage, with net and gross margins at 3.4% and 15.1% respectively, the return on invested capital generates only a narrow spread over the cost of equity. This results in an ROIC-WACC differential of just +0.9%, suggesting limited value creation from new investments despite strong financial stability indicators. The balance sheet remains robust with an Altman Z-Score of 3.3, indicating low bankruptcy risk, and operational resilience is further underscored by a Piotroski F-Score of 8/9, reflecting superior fundamental quality relative to peers even as revenue contraction persists at -1.1% year-over-year.
Valuation metrics currently reflect significant market skepticism regarding future growth trajectories despite the company's solid credit profile. Trading at a forward P/E multiple of 11.8x, which appears compressed relative to historical norms and sector averages given the high Piotroski score, implies that investors are heavily discounting earnings power rather than penalizing balance sheet weakness. A discounted cash flow analysis suggests an intrinsic fair value of $5229 per share; however, without explicit current market price data or implied growth rate assumptions provided in the input, determining whether this valuation represents a premium or discount requires external context not available within the supplied dataset. The divergence between high-quality fundamentals and negative revenue trends indicates that pricing is likely driven by concerns over top-line sustainability rather than solvency issues.
Risk assessment highlights a potential opportunity cost associated with low capital efficiency. Although the Altman Z-Score confirms minimal distress risk, the marginal ROIC-WACC spread of 0.9% suggests that shareholder value creation may lag behind alternative investments offering higher returns on similar-risk profiles. The combination of declining revenue and thin net margins creates an environment where even slight margin compression could erode the already modest economic moat. Consequently, while downside protection appears anchored by a strong balance sheet and high F-Score, upside potential remains constrained unless operational leverage improves or top-line dynamics reverse to support higher valuation multiples consistent with its fundamental quality scores.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6% | 7.4% | 9.4% |
|---|---|---|---|
| 2% | $17767 | $13038 | $9328 |
| 3% | $23076 | $15609 | $10523 |
| 4% | $33693 | $19703 | $12162 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=7.4%, terminal growth 3%. Fair value $15609 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like SCHF or IEFA, the fund manager is mechanically forced to buy or sell JP3634200004 shares regardless of JP3634200004's individual fundamentals. We estimate $18M of passive capital is structurally linked to JP3634200004 through 3 tracked ETFs. Passive flows have a limited but growing influence on JP3634200004's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 3 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in JP3634200004 to visualize passive redemption contagion across ETFs and collateral stocks.
If JP3634200004 (JP3634200004) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 2 ETFs with JP3634200004. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 3 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
JP3634200004 Ownership Dynamics
ETFs with Highest JP3634200004 Exposure
Float lock-up computed from 3 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
JP3634200004 Capital Efficiency
How efficiently does JP3634200004 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
JP3634200004 converts 28% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 72% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 0.0% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare JP3634200004 to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.